Récepteur dopaminergique < Récepteur dopaminergique D1 < Récepteur dopaminergique D2

Facettes :

List of bibliographic references indexed by Récepteur dopaminergique D1

Number of relevant bibliographic references: 13.

Ident.	Authors (with country if any)	Title
004406 (2002)	Marie-Paule Muriel [France] ; Gaël Orieux [France] ; Etienne C. Hirsch [France]	Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in parkinsonian rats
004721 (2001)	Marie-Paule Muriel [France] ; Yves Agid [France] ; Etienne Hirsch [France]	Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease
004A78 (2000)	Sarah A. Treseder [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Peter Jenner [Royaume-Uni]	Endogenous dopaminergic tone and dopamine agonist action
005070 (1998)	Michael Gassen [Allemagne] ; Aviva Gross [Israël] ; Moussa B. H. Youdim [Israël]	Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6‐Hydroxydopamine
005238 (1997)	Lise Rioux [États-Unis] ; Paul A. Frohna [États-Unis] ; Joyce [États-Unis] ; Jay S. Schneider [États-Unis]	The effects of chronic levodopa treatment on pre‐ and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys
005660 (1996)	L. Verhagen Metman [États-Unis] ; P. J. Blanchet [États-Unis] ; D. De Jong [États-Unis] ; M. M. Mouradian [États-Unis] ; Chase [États-Unis]	Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease
005665 (1996)	P. J. Blanchet [Canada] ; R. Grondin [Canada] ; Bédard [Canada]	Dyskinesia and wearing‐off following dopamine D1 agonist treatment in drug‐naive 1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐lesioned primates
005D35 (1993)	C. Anthony Hubbard [États-Unis] ; Trugman [États-Unis]	Reversal of reserpine‐induced catalepsy by selective D1 and D2 dopamine agonists
005E85 (1993)	B. Gomez-Mancilla [Canada] ; R. Boucher ; C. Gagnon ; T. Di Paolo ; R. Markstein ; P. J. Bedard	Effect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors
006097 (1992)	M. Emre [Suisse] ; U. K. Rinne ; A. Rascol ; A. Lees ; Yves Agid [France] ; X. Lataste	Effects of a selective partial D1 agonist, CY 208-243, in De Novo patients with Parkinson disease
006099 (1992)	B. Gomez-Mancilla [Canada] ; R. Boucher ; P. J. Bedard	Effect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of Parkinsonism
006476 (1989)	J. A. Temlett [Suisse] ; N. P. Quinn [Royaume-Uni] ; P. G. Jenner [Suisse] ; C. D. Marsden [Royaume-Uni] ; E. Pourcher [France] ; A. Bonnet [France] ; Yves Agid [France] ; R. Markstein [Suisse] ; X. Lataste [Suisse]	Antiparkinsonian activity of CY 208–243, a partial D‐1 dopamine receptor agonist, in MPTP‐treated marmosets and patients with Parkinson's disease
006510 (1989)	R. F. Pfeiffer ; L. H. Herrera ; C. S. Glaeske ; R. E. Hofman	CQP A01-403 in Parkinson's disease: an open-label pilot study

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Récepteur dopaminergique D1" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Récepteur dopaminergique D1" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Récepteur dopaminergique D1
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024